z-logo
open-access-imgOpen Access
The obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center
Author(s) -
Vatsla Dadhwal,
AK Sharma,
Dipika Deka,
Bindiya Gupta,
S. Mittal
Publication year - 2011
Publication title -
journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.74285
Subject(s) - medicine , pregnancy , intrauterine growth restriction , preeclampsia , obstetrics , aspirin , antiphospholipid syndrome , live birth , retrospective cohort study , fetus , thrombosis , surgery , genetics , biology
Antiphospholipid antibody syndrome (APAS) is regarded as the most frequently acquired risk factor for thrombophilia. The obstetric manifestations of APAS include early or late pregnancy losses and complications like preeclampsia and fetal growth restriction. Its timely diagnosis and treatment can improve maternal and neonatal outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom